Trial site
Delta Health Care S.R.L
- 35running trials
- 13closed trials
The trials here
What the 48 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis10 trials
- Lupus (SLE)9 trials
- Crohn's disease4 trials
- Lung cancer4 trials
- Asthma3 trials
- COPD2 trials
- Migraine2 trials
- Psoriasis2 trials
- Psoriatic arthritis2 trials
- Sjögren's disease2 trials
- Ankylosing spondylitis1 trial
- Atrial fibrillation1 trial
- and 9 more
- Phase
- Phase 331 trials
- Phase 215 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Recruiting22 trials
- Completed13 trials
- Active, not recruiting11 trials
- Not yet recruiting2 trials
- Lead sponsor
- Janssen Research & Development, LLC6 trials
- Abivax S.A.3 trials
- Eli Lilly and Company3 trials
- Merck Sharp & Dohme LLC3 trials
- Takeda3 trials
- and 23 more
Running trials
Recruiting
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Recruiting
Recruiting
Active, not recruiting
A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Recruiting
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Recruiting
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Recruiting
Active, not recruiting
Recruiting
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Enrolling by invitation
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Active, not recruiting
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)
Enrolling by invitation
Active, not recruiting
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis5 recruiting
- Crohn's disease4 recruiting
- Lupus (SLE)4 recruiting
- Lung cancer3 recruiting
- COPD2 recruiting
- Asthma1 recruiting
- Bladder cancer1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Colorectal cancer1 recruiting
- Prostate cancer1 recruiting
- Sjögren's disease1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Enrolling by invitation
Recruiting
Active, not recruiting
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)
Completed
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
Active, not recruiting
Completed
A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis
Site data: ClinicalTrials.govUpdated 18 Nov 2026